SC
PYXS icon

Schulhoff & Co’s Pyxis Oncology PYXS Stock Holding History

Schulhoff & Co’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-275,000
Closed -$611K – 137
2025
Q3 		$611K Hold
275,000
– – 0.26% 78
2025
Q2 		$303K Buy
275,000
+153,000
+125% +$172K 0.13% 110
2025
Q1 		$120K Hold
122,000
– – 0.05% 130
2024
Q4 		$190K Hold
122,000
– – 0.07% 125
2024
Q3 		$448K Buy
122,000
+80,000
+190% +$280K 0.19% 85
2024
Q2 		$139K Buy
42,000
+20,000
+91% +$84.1K 0.06% 125
2024
Q1 		$93.7K Hold
22,000
– – 0.04% 125
2023
Q4 		$39.6K Hold
22,000
– – 0.02% 121
2023
Q3 		$43.8K Buy
+22,000
New +$51K 0.02% 117

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schulhoff & Co's PYXS Position: Q4 2025 in Review

Schulhoff & Co sold out of Pyxis Oncology (PYXS) in Q4 2025, closing a stake of 275,000 shares — an estimated $611K sold.

Schulhoff & Co first reported a position in PYXS in Q3 2023 and held it in 9 quarters. The position peaked at $611K in Q3 2025. 79 funds tracked by Wall St. Rank hold PYXS as of Q4 2025.

  • Schulhoff & Co reported no remaining Pyxis Oncology position as of Q4 2025 after selling out during the quarter.
  • Schulhoff & Co sold 275,000 Pyxis Oncology shares in Q4 2025, an estimated $611K.
  • Schulhoff & Co first reported a position in Pyxis Oncology in Q3 2023 and held it in 9 quarters.
  • Schulhoff & Co's Pyxis Oncology position peaked at $611K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2025.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.